study
We should be wary of campaigns by pharmaceutical companies to destigmatise obesity
The BMJ · 1h ago
Eli Lilly
Medicine & Biotech · covered by 27 outlets this week · tracked since 2026-10-27
Press: 8 mainstream 43 specialist 7 independent outlet-days
Background
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 36 countries. Its products are marketed in approximately 90 countries. Wikipedia ↗
Written by the Alivewire editors from the coverage below, 19h ago. Not medical advice; how the ratings work.
Coverage
study
STAT+: Most-favored nations policy makes drugmakers rethink launches abroad
STAT Biotech · 5h ago
Retatrutide reduces sleep apnea severity in OSA plus obesity
Healio · 12h ago
USFDA Flags Potential Vision Loss Risk with Ozempic, Wegovy, Mounjaro, Seeks Label Warning Update
Medical Dialogues · 1d ago
FDA expands early breast cancer indication for abemaciclib with endocrine therapy
FDA Drug Safety / Drugs feed · 1d ago
pttranslation pending
Especialistas debatem resposta nacional à Obesidade e traçam novos caminhos com programa nacional de capacitação
News Farma · 1d ago
pttranslation pending
Justiça libera retomada do 'Bolsa Mounjaro' em Urupês com tirzepatida manipulada
G1 Saúde · 1d ago
frtranslation pending
Testachats dénonce des publicités déguisées pour des médicaments anti-obésité
RTBF Santé · 1d ago
FDA grants accelerated approval to pirtobrutinib for chronic lymphocytic leukemia and small lymphocytic lymphoma
FDA Drug Safety / Drugs feed · 2d ago
FDA approves selpercatinib for RET fusion-positive thyroid cancer
FDA Drug Safety / Drugs feed · 2d ago
FDA approves selpercatinib for medullary thyroid cancer with a RET mutation
FDA Drug Safety / Drugs feed · 2d ago
Weight-Loss Drugs May Help Sleep Apnea and Arthritis
Time Health · 2d ago
Oral GLP-1 reduces sleep apnea severity, cardiometabolic risk
Healio · 2d ago
Eli Lilly shows GLP-1 weight-loss pill Foundayo can dramatically improve sleep apnea
Scientific American (global) · 2d ago
study
STAT+: Eli Lilly’s GLP-1 pill Foundayo helped alleviate sleep apnea in studies
STAT News · 2d ago
frtranslation pending
« Attention, ces injections ne sont pas des régimes à coups de piqûres », Jean-Baptiste Cazauran, médecin nutritionniste à propos du Wegovy et de la rétatrutide
Science & Vie · 4d ago
FDA grants accelerated approval to selpercatinib for pediatric patients two years and older with RET-altered metastatic thyroid cancer or solid tumors
FDA Drug Safety / Drugs feed · 5d ago
Hims & Hers inks deal with Eli Lilly to offer branded weight loss drugs
Fierce Healthcare · 5d ago
Lilly strikes obesity drug access deal with Hims & Hers telehealth
EMJ Reviews · 5d ago
Lilly, Hims reach GLP-1 deal; Alnylam sales chief to step down
BioPharma Dive · 5d ago
Lilly partners with Hims & Hers on obesity drug sales
Pharmaphorum · 5d ago
estranslation pending
I Premios Minerva al Sector Privado de la Salud: Lilly, ganadora en la categoría 'Entidad del sector farmacéutico'
Redacción Médica · 5d ago
Novo gets much-needed lift as Wegovy pill tops Wall Street forecasts
BioPharma Dive · 7d ago
studyin animals
Celltrion's 4-hormone obesity drug beats Lilly's retatrutide on weight loss in rat study
Korea Biomedical Review · 7d ago
frtranslation pending
Le traitement anti-obésité Wegovy arrive en comprimé dans les pharmacies françaises
Sciences et Avenir Santé · 9d ago
studyrandomized trial
Eli Lilly drops Alzheimer’s drug candidate after phase II trial
Life Science Sweden · 12d ago
Earnings roundup: Lilly’s unwavering momentum, Novartis’ rebound and GSK’s waiting game
BioPharma Dive · 12d ago
Striking Results for Retatrutide in Obesity Plus Diabetes
ConscienHealth · 12d ago
Lilly's tirzepatide juggernaut is still gathering momentum
Pharmaphorum · 13d ago
Eli Lilly Revenue Climbs on Demand for Mounjaro, Zepbound
WSJ Health · 13d ago
Eli Lilly profits surge on demand for weight-loss drugs
Financial Times Health · 13d ago
Eli Lilly's 340B data policy draws new opposition from Missouri AG, Massachusetts hospitals
Fierce Healthcare · 14d ago
study
Retatrutide Helped People With Diabetes Lose Twice as Much Weight as Ozempic, New Trial Shows
Everyday Health · 14d ago
Counsel Health launches AI-native weight management program, inks partnership with Lilly Direct
Fierce Healthcare · 14d ago
study
Eli Lilly’s ‘Triple-G’ Drug Tops Ozempic in Head-to-Head Type 2 Diabetes Trial
MedCity News · 14d ago
Retatrutide reduces HbA1c, weight more than Ozempic in diabetes
Healio · 14d ago
Lilly shuffles business structure; Novartis writes off part of Avidity deal
BioPharma Dive · 14d ago
Lilly symposium at #36AEC explores the importance of timely diagnosis
Alzheimer Europe News · 14d ago
Oral GLP-1 Orforglipron (Foundayo) Achieves Weight Loss for Women of All Ages
Healthline · 15d ago
FDA Approves Lilly’s New Oral Combo Pill for Common Breast Cancer Mutation
Healthline · 15d ago
Bid to Block GLP-1 Ads Denied; First Weekly Insulin for T2D in Kids; Fertility Fell
MedPage Today · 15d ago
Court rejects Novo bid to block Lilly obesity drug ads
BioPharma Dive · 15d ago
study
STAT+: Nonprofit resurrects shelved gene therapy after startup shuts down
STAT Biotech · 15d ago
Judge backs Lilly in Novo lawsuit over weight-loss drug ads
Pharmaphorum · 15d ago
STAT+: Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction
STAT Health Tech · 20d ago
HSE considering reimbursing weight-loss drug Mounjaro
Irish Times Health · 27d ago
‘I just don’t understand it’
AJP (Australian Journal of Pharmacy) · 28d ago
GLP-1s in Ireland: How weight-loss medications work under the HSE system
Irish Times Health · 30d ago
Weight-loss drugs show signs of slowing biological aging, say drugmakers
MIT Technology Review Biotech · 36d ago
Lilly’s twin bets reshape diabetes weight loss
Longevity.Technology · 37d ago